Risk factors associated with increased mortality among HIV infected children initiating antiretroviral therapy (ART) in South Africa

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Zanoni, Brian C ^a,b,c   Phungula, Thuli ^c   Zanoni, Holly M ^c   France, Holly ^c   Feeney, Margaret E ^a,d  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MCCORD HOSPITAL   (South Africa)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; HEMOGLOBIN; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; RITONAVIR; STAVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

AGE; ARTICLE; CAUSE OF DEATH; CD4+ T LYMPHOCYTE; CHILD; CHILDHOOD MORTALITY; CHRONIC DIARRHEA; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SOUTH AFRICA; TREATMENT RESPONSE; TUBERCULOSIS; WEIGHT REDUCTION; ADOLESCENT; DRUG EFFECT; FOLLOW UP; HEALTH CARE QUALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS; MORTALITY; PATHOGENICITY; SURVIVAL RATE; TREATMENT OUTCOME; VIROLOGY;

ADOLESCENT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; ELECTRONIC HEALTH RECORDS; FEMALE; FOLLOW-UP STUDIES; HIV; HIV INFECTIONS; HUMANS; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; SOUTH AFRICA; STANDARD OF CARE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79960907498     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022706     Document Type: Article

References (35)

1. UNAIDS (2009) Aids Epidemic Update Geneva, Switzerland Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Orginization (WHO).
2. Taha TE, Graham SM, Kumwenda NI, Broadhead RL, Hoover DR, et al. (2000) Morbidity among human immunodeficiency virus-1-infected and-uninfected African children. Pediatrics 106: E77.
3. Prendergast A, Tudor-Williams G, Jeena P, Burchett S, Goulder P, (2007) International perspectives, progress, and future challenges of paediatric HIV infection. Lancet 370: 68-80.
4. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, Chintu N, Stringer EM, et al. (2007) Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA 298: 1888-1899.
5. Leyenaar JK, Novosad PM, Ferrer KT, Thahane LK, Mohapi EQ, et al. (2010) Early clinical outcomes in children enrolled in human immunodeficiency virus infection care and treatment in lesotho. Pediatr Infect Dis J 29: 340-345.
6. Havens PL, Gibb DM, (2007) Increasing antiretroviral drug access for children with HIV infection. Pediatrics 119: 838-845.
7. Kiboneka A, Wangisi J, Nabiryo C, Tembe J, Kusemererwa S, et al. (2008) Clinical and immunological outcomes of a national paediatric cohort receiving combination antiretroviral therapy in Uganda. AIDS 22: 2493-2499.
8. Bong CN, Yu JK, Chiang HC, Huang WL, Hsieh TC, et al. (2007) Risk factors for early mortality in children on adult fixed-dose combination antiretroviral treatment in a central hospital in Malawi. AIDS 21: 1805-1810.
9. Fenner L, Brinkhof MW, Keiser O, Weigel R, Cornell M, et al. (2010) Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa. J Acquir Immune Defic Syndr 54: 524-532.
10. Wamalwa DC, Obimbo EM, Farquhar C, Richardson BA, Mbori-Ngacha DA, et al. (2010) Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort. BMC Pediatr 10: 33.
11. Callens SF, Shabani N, Lusiama J, Lelo P, Kitetele F, et al. (2009) Mortality and associated factors after initiation of pediatric antiretroviral treatment in the Democratic Republic of the Congo. Pediatr Infect Dis J 28: 35-40.
12. Sterling TR, Lyles CM, Vlahov D, Astemborski J, Margolick JB, et al. (1999) Sex differences in longitudinal human immunodeficiency virus type 1 RNA levels among seroconverters. The Journal of infectious diseases 180: 666-672.
13. European Collaborative Study (2002) Level and pattern of HIV-1-RNA viral load over age: differences between girls and boys? AIDS 16: 97-104.
14. Foca M, Moye J, Chu C, Matthews Y, Rich K, et al. (2006) Gender differences in lymphocyte populations, plasma HIV RNA levels, and disease progression in a cohort of children born to women infected with HIV. Pediatrics 118: 146-155.
15. Farzadegan H, Hoover DR, Astemborski J, Lyles CM, Margolick JB, et al. (1998) Sex differences in HIV-1 viral load and progression to AIDS. Lancet 352: 1510-1514.
16. Richardson BA, Mbori-Ngacha D, Lavreys L, John-Stewart GC, Nduati R, et al. (2003) Comparison of human immunodeficiency virus type 1 viral loads in Kenyan women, men, and infants during primary and early infection. Journal of virology 77: 7120-7123.
17. South African National Department of Health (2004) National Antiretroviral Treatment Guidelines. Health NDo, eds. Johannesberg, South Africa Minutemann Press.
18. Collett D, (2003) Modeling Survival Data in Medical Research New York Chapman and Hall.
19. Yotebieng M, Van Rie A, Moultrie H, Cole SR, Adimora A, et al. (2010) Effect on mortality and virological response of delaying antiretroviral therapy initiation in children receiving tuberculosis treatment. AIDS 24: 1341-1349.
20. Reddi A, Leeper SC, Grobler AC, Geddes R, France KH, et al. (2007) Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa. BMC Pediatr 7: 13.
21. Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, et al. (2008) Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med 359: 2233-2244.
22. World Health Organization (2010) Antiretroviral Therapy for HIV Infection in Infants and Children: Toward Universal Access Geneva, Switzerland World Health Organization.
23. Meier A, Chang JJ, Chan ES, Pollard RB, Sidhu HK, et al. (2009) Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med 15: 955-959.
24. Sterling TR, Vlahov D, Astemborski J, Hoover DR, Margolick JB, et al. (2001) Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. N Engl J Med 344: 720-725.
25. Sterling TR, Lyles CM, Vlahov D, Astemborski J, Margolick JB, et al. (1999) Sex differences in longitudinal human immunodeficiency virus type 1 RNA levels among seroconverters. J Infect Dis 180: 666-672.
26. Gandhi M, Bacchetti P, Miotti P, Quinn TC, Veronese F, et al. (2002) Does patient sex affect human immunodeficiency virus levels? Clin Infect Dis 35: 313-322.
27. Sohler NL, Li X, Cunningham CO, (2009) Gender disparities in HIV health care utilization among the severely disadvantaged: can we determine the reasons? AIDS Patient Care STDS 23: 775-783.
28. Shapiro MF, Morton SC, McCaffrey DF, Senterfitt JW, Fleishman JA, et al. (1999) Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. JAMA 281: 2305-2315.
29. Box TL, Olsen M, Oddone EZ, Keitz SA, (2003) Healthcare access and utilization by patients infected with human immunodeficiency virus: does gender matter? J Womens Health (Larchmt) 12: 391-397.
30. Kipp W, Alibhai A, Saunders LD, Senthilselvan A, Kaler A, et al. (2010) Gender differences in antiretroviral treatment outcomes of HIV patients in rural Uganda. AIDS Care 22: 271-278.
31. Braitstein P, Boulle A, Nash D, Brinkhof MW, Dabis F, et al. (2008) Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration. J Womens Health (Larchmt) 17: 47-55.
32. Muula AS, Ngulube TJ, Siziya S, Makupe CM, Umar E, et al. (2007) Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review. BMC Public Health 7: 63.
33. Collazos J, Asensi V, Carton JA, (2007) Sex differences in the clinical, immunological and virological parameters of HIV-infected patients treated with HAART. AIDS 21: 835-843.
34. Chen SC, Yu JK, Harries AD, Bong CN, Kolola-Dzimadzi R, et al. (2008) Increased mortality of male adults with AIDS related to poor compliance to antiretroviral therapy in Malawi. Trop Med Int Health 13: 513-519.
35. Zanoni BC, Phungula T, Zanoni HM, France H, Feeney ME, (2011) Impact of tuberculosis cotreatment on viral suppression rates among HIV-positive children initiating HAART. AIDS 25: 49-55.